Interleukin-1R-associated kinase 2 is a novel modulator of the transforming growth factor β signaling cascade

Molecular Cancer Research

Volumn 8, Issue 4, 2010, Pages 592-603

  Mullenders, Jasper ^a   Fabius, Armida W M ^a   Van Dongen, Miranda M W ^a   Kuiken, Hendrik J ^a   Beijersbergen, Roderick L ^a   Bernards, René ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; PHOSPHOTRANSFERASE; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CYCLE ARREST; CELL NUCLEUS; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE LIBRARY; GENE TARGETING; GENETIC SCREENING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LOSS OF FUNCTION MUTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, CDC; GENETIC TESTING; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 77951180439     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0386     Document Type: Article

References (40)

1. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer 2003;3:807-821
2. Massague J. TGFβ in Cancer. Cell 2008;134:215-230
3. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005;19:2783-2810
4. Massague J, Gomis RR. The logic of TGFβ signaling. FEBS Lett 2006;580:2811-2820
5. Datto MB, Li Y, Panus JF, et al. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A 1995;92:5545-5549
6. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994;371:257-261
7. Seoane J, Pouponnot P, Staller P, et al. TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 2001;3:400-408
8. Bruna A, Darken RS, Rojo F, et al. High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 2007;11:147-160
9. Penuelas S, Anido J, Pieto-SanchezRM, et al. TGF-β increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 2009;15:315-327
10. Iyer S, Wang ZG, Akhtari M, Zhao W, Seth P. Targeting TGFβ signaling for cancer therapy. Cancer Biol Ther 2005;4:261-266
11. Colland F, Jacq X, Trouplin V, et al. Functional proteomics mapping of a human signaling pathway. Genome Res 2004;14:1324-1332
12. Barrios-Rodiles M, Brown KR, Ozdamar B, et al. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 2005;307:1621-1625
13. Levy L, Howell M, Das D, et al. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol 2007;27:6068-6083
14. Carpenter AE, Jones TR, Lamprecht MR, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 2006;7:R100.
15. Berns K, Hijmans EM, Mullenders J, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004;428:431-437
16. Dennler S, Itoh S, Vivien D, et al. Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998;17:3091-3100
17. Oh SP, Seki T, Goss KA, et al. Activin receptor-like kinase 1 modulates transforming growth factor-β 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 2000;97:2626-2631
18. Goumans MJ, Valdimarsdottir G, Itoh S, et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFβ/ALK5 signaling. Mol Cell 2003;12:817-828
19. Perrimon N, Mathey-Prevot B. Matter arising: off-targets and genome-scale RNAi screens in Drosophila. Fly (Austin) 2007;1:1-5.
20. Svoboda P. Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr Opin Mol Ther 2007;9:248-257
21. Echeverri CJ, Beachy PA, Baum B, et al. Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods 2006;3:777-779
22. Kawagoe T, Sato S, Matsushita K, et al. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat Immunol 2008;9:684-691
23. Bachman KE, Blair BG, Brenner K, et al. p21(WAF1/CIP1) mediates the growth response to TGF-β in human epithelial cells. Cancer Biol Ther 2004;3:221-225
24. Kortlever RM, Nijwening JH, Bernards R. Transforming growth factor-β requires its target plasminogen activator inhibitor-1 for cytostatic activity. J Biol Chem 2008;283:24308-24313
25. Abdollah S, Macias-Silva M, Tsukazaki T, et al. TβRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-4 complex formation and signaling. J Biol Chem 1997;272:27678-27685
26. Liu Q, Huang SS, Huang JS. Function of the type V transforming growth factor β receptor in transforming growth factor β-induced growth inhibition of mink lung epithelial cells. J Biol Chem 1997; 272:18891-18895
27. Souchelnytskyi S, Tamaki K, Engstrom U, et al. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J Biol Chem 1997;272:28107-28115
28. Firestein R, Bass AJ, Kim SY, et al. CDK8 is a colorectal cancer oncogene that regulates β-catenin activity. Nature 2008;455:547-551
29. Ma Y, Creanga A, Lum L, Beachy PA. Prevalence of off-target effects in Drosophila RNA interference screens. Nature 2006;443:359-363
30. Tang W, Dodge M, Gundapaneni P, et al. A genome-wide RNAi screen for Wnt/β-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. Proc Natl Acad Sci U S A 2008;105:9697-9702
31. Yang YC, Piek E, Zavadil J, et al. Hierarchical model of gene regulation by transforming growth factor β. Proc Natl Acad Sci U S A 2003; 100:10269-10274
32. Piek E, Ju WJ, Heyer J, et al. Functional characterization of transforming growth factor β signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem 2001;276:19945-19953
33. Brown KA, Pietenpol JA, Moses HL. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-β signaling. J Cell Biochem 2007;101:9-33.
34. Yang J, Wahdan-Alaswad R, Danielpour D. Critical role of Smad2 in tumor suppression and transforming growth factor-β-induced apoptosis of prostate epithelial cells. Cancer Res 2009;69:2185-2190
35. Janssens S, Beyaert R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell 2003;11:293-302.
36. Hanks SK, Hunter T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 1995;9:576-596
37. Muzio M, Ni J, Peng F, Dixit VM. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997; 278:1612-1615
38. Keating SE, Maloney GM, Moran EM, Bowie AG. IRAK-2 participates in multiple toll-like receptor signaling pathways to NFκB via activation of TRAF6 ubiquitination. J Biol Chem 2007;282:33435-33443
39. Yamashita M, FatyolK, Jin C, et al. TRAF6mediatesSmad-independent activation of JNK and p38 by TGF-β. Mol Cell 2008;31:918-924
40. Lu T, Tian L, Han Y, Vogelbaum M, Stark GR. Dose-dependent cross-talk between the transforming growth factor-β and interleukin-1 signaling pathways. Proc Natl Acad Sci U S A 2007;104:4365-4370 (Pubitemid 47186232)